Business
Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision
Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision
About this update from Enorama Pharma Ab
Enorama Pharma AB OMXSTO:ERMA:SUBSIDIARY INTENDS TO APPEAL FDA'S RTF DECISIONCOMPANY IN CONTACT WITH FDA FOR CLARITY ON REGULATORY STATUSANALYZING FDA DECISION AND EVALUATING CONSEQUENCES